FLAMAZINE

This brand name is authorized in Australia, Canada, Hong Kong, Ireland, New Zealand, Singapore, United Kingdom, South Africa

Active ingredients

The drug FLAMAZINE contains one active pharmaceutical ingredient (API):

1 Silver sulfadiazine UNII W46JY43EJR - SILVER SULFADIAZINE

Silver sulfadiazine is a sulfonamide and has broad antimicrobial activity against both Gram-positive and Gram-negative organisms including Pseudomonas aeruginosa, some yeasts and fungi. Silver sulfadiazine acts on the cell membrane and cell wall. Read about Silver sulfadiazine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FLAMAZINE Cream	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06BA01	Silver sulfadiazine	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BA Sulfonamides
Discover more medicines within D06BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 9479X
Country: CA	Health Products and Food Branch	Identifier(s): 00323098
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 34458, 34459, 34460
Country: HK	Department of Health Drug Office	Identifier(s): 08615
Country: IE	Health Products Regulatory Authority	Identifier(s): 79537, 79545, 79553
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13877, 13878
Country: SG	Health Sciences Authority	Identifier(s): 04671P
Country: ZA	Health Products Regulatory Authority	Identifier(s): H/14.2/3003